Skip to main content
. 2012 Nov 9;24(1):58–66. doi: 10.1089/hum.2012.163

FIG. 4.

FIG. 4.

Anti-Ad5 antibody titers before and after dAd5 haptenic vaccine administered. BALB/c mice (n=10/group) were immunized intramuscularly with 2×1010 particle units Ad5Null at −10, −6 and −2 weeks, followed by vaccination with dAd5GNE or dAd5AM1 (4 μg each) at 0, 3, and 6 weeks compared to naive control mice (n=10/group) vaccinated with dAd5GNE or dAd5AM1 at 0, 3, and 6 weeks. (A) Serum anti-Ad5 antibody titers in dAd5GNE vaccine-administered mice, assessed by ELISA at −10, 0, 3, 6, and 8 weeks in naive and Ad5-preimmune mice. (B) Serum anti-Ad5 antibody titers in dAd5AM1 vaccine-administered mice, assessed by ELISA at −10, 0, 2, 5, and 8 weeks in naive and Ad-preimmune mice. Antibody titers are mean values±SEM.